ASTEC LIFESCIENCES
|
ASTEC LIFESCIENCES Last 5 Year Financial Ratios History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | -36.31 | -68.71 | -23.93 | 13.04 | 45.85 |
| CEPS(Rs) | -16.14 | -46.06 | -5.39 | 30.00 | 62.94 |
| DPS(Rs) | - | - | - | 1.50 | 1.50 |
| Book NAV/Share(Rs) | 175.24 | 119.64 | 188.13 | 213.72 | 202.17 |
| Tax Rate(%) | 0.15 | 4.45 | 24.06 | 26.76 | 25.79 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | -1.01 | -17.00 | -1.29 | 12.08 | 22.66 |
| EBIT Margin(%) | -10.37 | -26.78 | -7.95 | 8.82 | 19.15 |
| Pre Tax Margin(%) | -18.07 | -36.21 | -13.44 | 5.54 | 17.82 |
| PAT Margin (%) | -18.05 | -34.60 | -10.21 | 4.05 | 13.22 |
| Cash Profit Margin (%) | -8.02 | -23.37 | -2.32 | 9.39 | 18.27 |
| Performance Ratios | |||||
| ROA(%) | -8.84 | -14.47 | -4.80 | 2.69 | 11.21 |
| ROE(%) | -25.88 | -44.64 | -11.90 | 6.28 | 25.50 |
| ROCE(%) | -5.71 | -12.62 | -4.50 | 7.75 | 22.21 |
| Asset Turnover(x) | 0.49 | 0.42 | 0.47 | 0.66 | 0.85 |
| Sales/Fixed Asset(x) | 0.60 | 0.58 | 0.85 | 1.31 | 1.72 |
| Working Capital/Sales(x) | -7.89 | -15.84 | 344.64 | -23.08 | 27.10 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 1.68 | 1.72 | 1.18 | 0.76 | 0.58 |
| Receivable days | 160.92 | 148.32 | 128.71 | 123.89 | 123.70 |
| Inventory Days | 121.29 | 166.70 | 194.99 | 139.29 | 78.67 |
| Payable days | 103.52 | 105.03 | 152.31 | 166.93 | 150.04 |
| Valuation Parameters | |||||
| PER(x) | - | - | - | 106.02 | 38.22 |
| PCE(x) | -33.43 | -14.54 | -195.78 | 45.75 | 27.64 |
| Price/Book(x) | 3.08 | 5.64 | 5.65 | 6.47 | 8.67 |
| Yield(%) | - | - | - | 0.11 | 0.09 |
| EV/Net Sales(x) | 3.66 | 4.92 | 5.62 | 4.85 | 5.49 |
| EV/Core EBITDA(x) | 3,007.12 | -30.96 | -9,579.67 | 34.14 | 22.56 |
| EV/EBIT(x) | -35.26 | -17.98 | -70.48 | 54.78 | 28.51 |
| EV/CE(x) | 1.95 | 2.38 | 2.98 | 4.01 | 5.49 |
| M Cap / Sales | 2.68 | 3.47 | 4.55 | 4.31 | 5.08 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 17.53 | -16.78 | -27.06 | -7.15 | 21.93 |
| Core EBITDA Growth(%) | 100.90 | - | -100.30 | -45.72 | 37.72 |
| EBIT Growth(%) | 55.44 | -185.56 | -165.61 | -57.24 | 38.76 |
| PAT Growth(%) | 39.96 | -187.29 | -283.21 | -71.53 | 38.13 |
| EPS Growth(%) | 47.15 | -187.11 | -283.54 | -71.56 | 38.07 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 1.15 | 2.36 | 1.34 | 0.81 | 0.71 |
| Current Ratio(x) | 0.89 | 0.93 | 1.00 | 0.95 | 1.05 |
| Quick Ratio(x) | 0.61 | 0.50 | 0.51 | 0.39 | 0.67 |
| Interest Cover(x) | -1.35 | -2.84 | -1.45 | 2.69 | 14.37 |
| Total Debt/Mcap(x) | 0.37 | 0.42 | 0.24 | 0.13 | 0.08 |
Compare Financial Ratios of peers of ASTEC LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ASTEC LIFESCIENCES | ₹1,506.5 Cr | -1% | -15.3% | -25.9% | Stock Analytics | |
| UPL | ₹52,186.6 Cr | 3.3% | 1.7% | -8.2% | Stock Analytics | |
| PI INDUSTRIES | ₹40,677.9 Cr | 2.3% | -4.4% | -34.4% | Stock Analytics | |
| SUMITOMO CHEMICAL INDIA | ₹27,003.8 Cr | 0.2% | 19.6% | -0.2% | Stock Analytics | |
| BAYER CROPSCIENCE | ₹19,560.4 Cr | 5.8% | 1.8% | -31.6% | Stock Analytics | |
| SHARDA CROPCHEM | ₹7,931.7 Cr | -3.3% | -2.5% | 13.3% | Stock Analytics | |
ASTEC LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ASTEC LIFESCIENCES | -1% |
-15.3% |
-25.9% |
| SENSEX | 0.5% |
0.1% |
-6.1% |
You may also like the below Video Courses
